ADIPOQ and metabolic dysfunction-associated steatotic liver disease: It has been shown that nonalcoholic fatty liver disease, chronic alcoholic fatty liver diseases, and chronic hepatitis C were associated with reduced serum adiponectin levels, decreased hepatic adiponectin receptor expression, and impaired hepatic adiponectin signaling [20].